Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update (Q34286094)

1 August 2017

9 references

13 March 2019

14 March 2019

24 March 2019

17 June 2019

20 August 2019

21 December 2019

20 September 2020

4 February 2021

20 October 2022

Glyco-oxidation and cardiovascular complications in type 2 diabetes: a clinical update (English)

1 reference

1 August 2017

3 references

20 August 2019

21 December 2019

4 February 2021

cardiovascular disease

7 references

13 March 2019

14 March 2019

24 March 2019

17 June 2019

20 August 2019

21 December 2019

20 September 2020

physiological phenomenon

1 reference

protein degradation end products

20 August 2019

1 reference

21 December 2019

0 references

Francesco Piarulli

1

1 reference

1 August 2017

Giovanni Sartore

series ordinal

2

1 reference

1 August 2017

Annunziata Lapolla

series ordinal

3

1 reference

1 August 2017

5 July 2012

1 reference

1 August 2017

1 April 2013

8 references

13 March 2019

14 March 2019

24 March 2019

17 June 2019

20 August 2019

21 December 2019

4 February 2021

20 October 2022

9 references

1 August 2017

13 March 2019

14 March 2019

24 March 2019

17 June 2019

20 August 2019

21 December 2019

4 February 2021

20 October 2022

50

1 reference

1 August 2017

101-110

1 reference

1 August 2017

2

1 reference

Creative Commons Attribution 4.0 International

1 August 2017

1 reference

https://scigraph.springernature.com/pub.10.1007/s00592-012-0412-3

20 October 2022

exact match

0 references

cites work

Serum level of endogenous secretory receptor for advanced glycation end products and other factors in type 2 diabetic patients with mild cognitive impairment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Total soluble and endogenous secretory receptor for advanced glycation end products as predictive biomarkers of coronary heart disease risk in patients with type 2 diabetes: an analysis from the CARDS trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Some views on proteomics in diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Higher plasma levels of advanced glycation end products are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Oxidative stress and diabetic complications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Metabolic memory: a vascular perspective

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Higher plasma soluble Receptor for Advanced Glycation End Products (sRAGE) levels are associated with incident cardiovascular disease and all-cause mortality in type 1 diabetes: a 12-year follow-up study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Soluble forms of RAGE in internal medicine.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Plasma carboxymethyl-lysine, an advanced glycation end product, and all-cause and cardiovascular disease mortality in older community-dwelling adults

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Decreased serum esRAGE level is associated with angiographically determined coronary plaque progression in diabetic patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Advanced glycation end-products in senile diabetic and non-diabetic patients with cardiovascular complications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

RAGE: a novel biological and genetic marker for vascular disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

10-year follow-up of intensive glucose control in type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Role of N-(carboxymethyl)lysine in the development of ischemic heart disease in type 2 diabetes mellitus.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Receptor for advanced glycation endproducts and atherosclerosis: From basic mechanisms to clinical implications.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Soluble forms of RAGE: an index of vascular stress? A commentary on "Soluble RAGE in type 2 diabetes: association with oxidative stress".

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Advanced glycation end products: sparking the development of diabetic vascular injury

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Intensive Diabetes Treatment and Cardiovascular Disease in Patients with Type 1 Diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Glycation, inflammation, and RAGE: a scaffold for the macrovascular complications of diabetes and beyond

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Diabetes and advanced glycation endproducts

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Biochemistry and molecular cell biology of diabetic complications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Diabetes and mass spectrometry

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Advanced glycation end-products: a review

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

RAGE: a multiligand receptor contributing to the cellular response in diabetic vasculopathy and inflammation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Increased serum concentrations of advanced glycation end products: a marker of coronary artery disease activity in type 2 diabetic patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Oxidative stress and diabetic vascular complications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Immunohistochemical localization of advanced glycosylation end products in coronary atheroma and cardiac tissue in diabetes mellitus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Nonenzymatic glycosylation in vitro and in bovine endothelial cells alters basic fibroblast growth factor activity. A model for intracellular glycosylation in diabetes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

The oxidation hypothesis of atherosclerosis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Diabetes and atherosclerosis: an epidemiologic view

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Absence of brown product FFI in nondiabetic and diabetic rat collagen

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Laminin alterations after in vitro nonenzymatic glycosylation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Advanced glycosylation: chemistry, biology, and implications for diabetes and aging

6 July 2018

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

6 July 2018

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Pentosidine formation in skin correlates with severity of complications in individuals with long-standing IDDM

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Glycation of lipoproteins and accelerated atherosclerosis in non-insulin-dependent diabetes mellitus.

6 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Degradation products of proteins damaged by glycation, oxidation and nitration in clinical type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Laminin alterations after in vitro nonenzymatic glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Autoantibodies against oxidized LDLs and atherosclerosis in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Relationship between glyco-oxidation, antioxidant status and microalbuminuria in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Soluble RAGE but not endogenous secretory RAGE is associated with albuminuria in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Increased serum levels of advanced glycation endproducts predict total, cardiovascular and coronary mortality in women with type 2 diabetes: a population-based 18 year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Evaluation of advanced glycation end products and carbonyl compounds in patients with different conditions of oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Cardiac troponin T and advanced glycation end-products in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Increased glycated albumin and decreased esRAGE levels are related to angiographic severity and extent of coronary artery disease in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Soluble receptor of advanced glycated endproducts is associated with plaque vulnerability in patients with acute myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Association between sRAGE, esRAGE levels and vascular inflammation: analysis with (18)F-fluorodeoxyglucose positron emission tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Subclinical diastolic dysfunction in type 2 diabetic patients with and without carotid atherosclerosis: relationship with glyco-oxidation, lipid-oxidation and antioxidant status.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3634985

Advanced Glycation End Products and Antioxidant Status in Type 2 Diabetic Patients With and Without Peripheral Artery Disease

28 October 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00592-012-0412-3

Peripheral artery disease in type 2 diabetes: the role of fibrinolysis

21 January 2018

1 reference

12 December 2020

Elevated soluble receptor for advanced glycation end product levels in patients with acute coronary syndrome and positive cardiac troponin I

1 reference

12 December 2020

In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques

1 reference

12 December 2020

Role of oxidative stress in diabetic complications: a new perspective on an old paradigm

1 reference

12 December 2020

Is glycation of low density lipoproteins in patients with Type 2 diabetes mellitus a LDL pre-oxidative condition?

1 reference

12 December 2020

Increased serum HMGB1 level is associated with coronary artery disease in nondiabetic and type 2 diabetic patients.

1 reference

12 December 2020

10.1007/S00592-012-0412-3

Identifiers

DOI

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference